Oppenheimer & Co: Recombinant Products Win Out; Initiating With An Outperform

A new analyst report from Oppenheimer & Co. Inc. is published. Recombinant Products Win Out; Initiating With An Outperform Contact [...]

Pharming publiceert resultaten over de eerste negen maanden van 2017

Forse toename van omzet geeft stimulus aan operationele winstgevendheid en cashflow Sterke vooruitzichten met verder toenemende omzet in de rest [...]

october